AW
AMPH icon

Avion Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

Avion Wealth’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24
Closed – – 1412
2026
Q1 		$0 Sell
24
-60
-71% -$1.47K ﹤0.01% 1217
2025
Q4 		$2K Sell
84
-40
-32% -$1.03K ﹤0.01% 838
2025
Q3 		$3K Buy
124
+64
+107% +$1.65K ﹤0.01% 720
2025
Q2 		$1K Buy
+60
New +$1.49K ﹤0.01% 896

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Avion Wealth's AMPH Position: Q2 2026 in Review

Avion Wealth sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 24 shares.

Avion Wealth first reported a position in AMPH in Q2 2025 and held it in 4 quarters. The position peaked at $3K in Q3 2025. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Avion Wealth reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Avion Wealth sold 24 Amphastar Pharmaceuticals shares in Q2 2026.
  • Avion Wealth first reported a position in Amphastar Pharmaceuticals in Q2 2025 and held it in 4 quarters.
  • Avion Wealth's Amphastar Pharmaceuticals position peaked at $3K in Q3 2025.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.